In addition conflict of interest with which one authorizes to the health coming directly from the manufacturer and delaying the prohibition obtained thanks to the fierce heroic of a doctor !!
Otherwise we would continue to prescribe it !!
The power of lobbies kills, health and elsewhere!
In addition justice has banned the title of the book: pick: how many deaths, on request of the manufacturer!
http://www.enviro2b.com/2010/10/21/medi ... ou-%C2%BB/
http://www.eugenol.com/sujets/390491-me ... nce-mortel
1998 Dice we knew !!
How many other drugs and dangerous products are hidden?
The whistleblowers are not swarming against the lobbies !!
Frightening:
Irene Frachon, a pulmonologist at Brest University Hospital, is the author of Mediator 150 mg, censored subtitle » to Dialogues editions. Denouncing in this book the damage of this drug on thousands of victims who are still unaware, the Breton doctor evokes a real health bomb delayed, ...
It is officially an antidiabetic and informally an appetite suppressant ...
massively been used as appetite suppressant in people without diabetes ...
So it was put on the market in 1976 and banned in 2009, that's why it did so much damage! More than two million people have consumed Mediator ...
The scientific proof was then given that this drug exposes to a risk rare but not so exceptional, of the order of 0,5 / 1000 people who have consumed, destruction of the heart valves, causing a valve insufficiency often multiple. In 1997, Isomeride, a close cousin of the Mediator, marketed by the same Servier laboratory, was removed from the market because it could destroy heart valves. Once absorbed, it was found that Isomeride was transformed into a kind of small "poison", norfenfluramine, which gradually destroys the heart valves.
However, during its absorption, the Mediator is transformed into the same "poison". So it's not exactly the same molecule, but it's the same family, and if you consume one or the other, you're probably exposed to a cardiac risk in the same way. However, Isomeride was banned in 1997 and the Picks only in 2009. Today I still do not understand the reason.
A reconciliation had been made since there are reports of Afssaps commissions dating from 1998 that mention the risk associated with the presence of norfenfluramine, after absorption of Mediator. Afssaps then decided to monitor this risk, but without warning anyone, prescribers or consumers. In addition, valvulopathies were regularly notified to Afssaps from 1999. So the doctors did not receive any recommendations about the Mediator until it was banned in 2009.
On the other hand, the curious ones who wanted to know more about the Mediator, because they had heard about a problem, called the laboratory that markets this medicine to obtain information. But the laboratory answers that I had access to were that this drug has no relation to Isomeride.